Mood disorders, psychopharmacology and thyroid hormones;Trastornos del ánimo, psicofármacos y tiroides

Revista Medica de Chile

Volumn 132, Issue 11, 2004, Pages 1413-1424

  Quiroz L, Danilo ^a   Gloger K, Sergio ^a   Valdivieso F, Sergio ^b   Ivelic Z, José ^b   Fardella B, Carlos ^b  

^a Ctro Invest Clinicas PsicoMedica

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Mood disorders; Psychopharmacology

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; DEIODINASE; GABAPENTIN; LAMOTRIGINE; LIOTHYRONINE; NEUROLEPTIC AGENT; OXCARBAZEPINE; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; THYROXINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ADD ON THERAPY; CENTRAL NERVOUS SYSTEM; DEPRESSION; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION REGULATION; HORMONE ACTION; HUMAN; MOOD DISORDER; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PHARMACOGENETICS; PSYCHOPHARMACOLOGY; REVIEW; SEROTONINERGIC SYSTEM; THYROID DISEASE; THYROID FUNCTION TEST; DRUG EFFECT; DRUG INTERACTION; HYPERTHYROIDISM; HYPOTHYROIDISM; METABOLISM; THYROID GLAND;

CENTRAL NERVOUS SYSTEM; DRUG INTERACTIONS; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MOOD DISORDERS; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE;

EID: 17444426314     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. YEN PM. Physiological and Molecular Basis of Thyroid Hormone Action. Physiol Rev 2001; 81: 1097-142.
2. BAUER M, SZUBA MP, WHYBROW P. Psychiatric and Behavioral Manifestations of Hyperthyroidism and Hypothyroidism. En: Psychoneuroendocrinology: The Scientific Basis of Clinical Practice. Rothschild, AJ, American Psychiatric Publishing, Inc., 2003; 419-44.
3. FARDELLA C, GLOGER S, FIGUEROA R, SANTIS R, GAJARDO C, SALGADO C ET AL. High Prevalence of Thyroid Abnormalities in a Chilean Psychiatric Outpatient Population. J Endocrinol Invest 2000; 23: 102-6.
4. PRANGE AJ J, HAGGERTY JJ JR, BROWNE JL, RICE J. Marginal Hypothyroidism in Mental Illness: Preliminary Assessment of Prevalence and Significance. En: Neuropsychopharmacology. Schmauss, M., 1990; 1: 352-61.
5. GOLD MS, POTTASH AL, EXTEIN I. Hypothyroidism and Depression. Evidence from Complete Thyroid Function Evaluation. JAMA 1981; 245: 1919-22.
6. COOPER DS. Subclinical Hypothyroidism. N Engl J Med 2001; 345: 260-5.
7. TALLIS F. Primary Hypothyroidism: A Case for Vigilance in the Psychological Treatment of Depression. Br J Clin Psychol 1993; 32 (Pt 3): 261-70.
8. HOWLAND RH. Thyroid Dysfunction in Refractory Depression: Implications for Pathophysiology and Treatment. J Clin Psychiatry 1993; 54: 47-54.
9. GLOGER S, FARDELLA C, SANTIS R, BITRÁN J. Relevance of the Thyroid Function Assessment in Psychiatric Patients. Rev Méd Chile 1991; 125: 1351-6.
10. HAGGERTY JJ JR, PRANGE AJ JR. Borderline Hypothyroidism and Depression. Annu Rev Med 1995; 46: 37-46.
11. COLE DP, THASE ME, MALLINGER AG, SOARES JC, LUTHER JF, KUPFER DJ ET AL. Slower Treatment Response in Bipolar Depression Predicted by Lower Pretreatment Thyroid Function. Am J Psychiatry 2002; 159: 116-21.
12. BUNEVICIUS R, JAKUBONIEN N, JURKEVICIUS R, CERNICAT J, LASAS L, PRANGE AJ JR. Thyroxine vs Thyroxine Plus Triiodothyronine in Treatment of Hypothyroidism after Thyroidectomy for Graves' Disease. Endocrine 2002; 18: 129-33.
13. BUNEVICIUS R, PRANGE AJ. Mental Improvement after Replacement Therapy with Thyroxine Plus Triiodothyronine: Relationship to Cause of Hypothyroidism. Int J Neuropsychopharmacol 2000; 3: 167-74.
14. SAWKA AM, GERSTEIN HC, MARRIOTT MJ, MACQUEEN GM, JOFFE RT. Does a Combination Regimen of Thyroxine (T4) and 3,5,3′-Triiodothyronine Improve Depressive Symptoms Better Than T4 Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial. J Clin Endocrinol Metab 2003; 88: 4551-5.
15. CLYDE PW, HARARI AE, GETKA EJ, SHAKIR KM. Combined Levothyroxine Plus Liothyronine Compared with Levothyroxine Alone in Primary Hypothyroidism: A Randomized Controlled Trial. JAMA 2003; 290: 2952-8.
16. EVANS DL, STRAWN SK, HAGGERTY JJ JR, GARBUTT JC, BURNETT GB, PEDERSEN CA. Appearance of Mania in Drug-Resistant Bipolar Depressed Patients after Treatment with L-Triiodothyronine. J Clin Psychiatry 1986; 47: 521-2.
17. WHYBROW PC. The Therapeutic Use of Triiodothyronine and High Dose Thyroxine in Psychiatric Disorder. Acta Med Austriaca 1994; 21: 47-52.
18. PRANGE AJ J, WILSON IC, RAYBON SM. Enhancement of Imipramine Antidepressant Activity by Thyroid Hormone. Am J Psychiatry 1969; 126: 457-69.
19. WILSON IC, PRANGE AJ J, MCCLANE TK. Thyroid Hormone Enhancement of Imipramine in Nonretarded Depression. N Engl J Med 1970; 282: 1063-7.
20. ALTSHULER LL, BAUER M, FRYE MA, GITLIN MJ, MINTZ J, SZUBA MP ET AL. Does Thyroid Supplementation Accelerate Tricyclic Antidepressant Response? A Review and Meta-Analysis of the Literature. Am J Psychiatry 2001; 158: 1617-22.
21. ALTSHULER LL, FRYE MA, GITLIN MJ. Acceleration and Augmentation Strategies for Treating Bipolar Depression. Biol Psychiatry 2003; 53: 691-700.
22. JOFFE RT, SINGER W, LEVITT AJ, MACDONALD C. A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression. Arch Gen Psychiatry 1993; 50: 387-93.
23. JOFFE RT, SINGER W. A Comparison of Triiodothyronine and Thyroxine in the Potentiation of Tricyclic Antidepressants. Psychiatry Res 1990; 32: 241-51.
24. THASE ME, KUPFER DJ, JARRETT DB. Treatment of Imipramine-Resistant Recurrent Depression, I: An Open Clinical Trial Od Adjuntive L-Triiodothyronine. J Clin Psychiatry 1989; 50: 385-8.
25. SPOOV J, LAHDELMA L. Should Thyroid Augmentation Precede Lithium Augmentation a Pilot Study. J Affect Disord 1998; 49: 235-9.
26. ARONSON R, OFFMAN HJ, JOFFE RT, NAYLOR CD. Triiodothyronine Augmentation in the Treatment of Refractory Depression. A Meta-Analysis. Arch Gen Psychiatry 1996; 53: 842-8.
27. STERN RA, NEVELS CT, SHELHORSE ME, PROHASKA ML, MASON GA, PRANGE AJ JR. Antidepressant and Memory Effects of Combined Thyroid Hormone Treatment and Electroconvulsive Therapy: Preliminary Findings. Biol Psychiatry 1991; 30: 623-7.
28. STERN RA, WHEALIN JM, MASON GA, NOONAN LR, SILVA SG, ARRUDA JE ET AL. Influence of L-Triiodothyronine on Memory Following Repeated Electroconvulsive Shock in Rats: Implications for Human Electroconvulsive Therapy. Biol Psychiatry 1995; 37: 198-201.
29. RUDAS S, SCHMITZ M, PICHLER P, BAUMGARTNER A. Treatment of Refractory Chronic Depression and Dysthymia with High-Dose Thyroxine. Biol Psychiatry 1999; 45: 229-33.
30. BAUER M, HELLWEG R, GRAF KJ, BAUMGARTNER A. Treatment of Refractory Depression with High-Dose Thyroxine. Neuropsychopharmacology 1998; 18: 444-55.
31. BAUER MS, WHYBROW PC. Rapid Cycling Bipolar Affective Disorder. II. Treatment of Refractory Rapid Cycling with High-Dose Levothyroxine: A Preliminary Study. Arch Gen Psychiatry 1990; 47: 435-40.
32. BAUER M, PRIEBE S, BERGHOFER A, BSCHOR T, KIESSLINGER U, WHYBROW PC. Subjective Response to and Tolerability of Long-Term Supraphysiological Doses of Levothyroxine in Refractory Mood Disorders. J Affect Disord 2001; 64: 35-42.
33. GYULAI L, JAGGI J, BAUER MS, YOUNKIN S, RUBIN L, ATTIE M ET AL. Bone Mineral Density and L-Thyroxine Treatment in Rapidly Cycling Bipolar Disorder. Biol Psychiatry 1997; 41: 503-6.
34. GYULAI L, BAUER M, GARCIA-ESPANA F, HIERHOLZER J, BAUMGARTNER A, BERGHOFER A ET AL. Bone Mineral Density in Pre-and Post-Menopausal Women with Affective Disorder Treated with Long-Term L-Thyroxine Augmentation. J Affect Disord 2001; 66: 185-91.
35. REDEI EE, SOLBERG LC, KLUCZYNSKI JM, PARE WP. Paradoxical Hormonal and Behavioral Responses to Hypothyroid and Hyperthyroid States in the Wistar-Kyoto Rat. Neuropsychopharmacology 2001; 24: 632-9.
36. SOKOLOFF L, WECHSLER RL, MANGOLD R, BALLS K, KETY SS. Cerebral Blood Flow and Oxygen Consumption in Hyperthyroidism before and after Treatment. J Clin Invest 1953; 32: 202-8.
37. FARSETTI A, MITSUHASHI T, DESVERGNE B, ROBBINS J, NIKODEM VM. Molecular Basis of Thyroid Hormone Regulation of Myelin Basic Protein Gene Expression in Rodent Brain. J Biol Chem 1991; 266: 23226-32.
38. FARSETTI A, DESVERGNE B, HALLENBECK P, ROBBINS J, NIKODEM VM. Characterization of Myelin Basic Protein Thyroid Hormone Response Element and Its Function in the Context of Native and Heterologous Promoter. J Biol Chem 1992; 267: 15784-8.
39. STRAIT KA, SCHWARTZ HL, SEYBOLD VS, LING NC, OPPENHEIMER JH. Immunofluorescence Localization of Thyroid Hormone Receptor Protein Beta 1 and Variant Alpha 2 in Selected Tissues: Cerebellar Purkinje Cells as a Model for Beta 1 Receptor-Mediated Developmental Effects of Thyroid Hormone in Brain. Proc Nail Acad Sci USA 1991; 88: 3887-91.
40. CARLSON DJ, STRAIT KA, SCHWARTZ HL, OPPENHEIMER JH. Thyroid Hormone Receptor Isoform Content in Cultured Type 1 and Type 2 Astrocytes. Endocrinology 1996; 137: 911-7.
41. DRATMAN MB, FUTAESAKU Y, CRUTCHFIELD FL, BERMAN N, PAYNE B, SAR M ET AL. Iodine-125-Labeled Triiodothyronine in Rat Brain: Evidence for Localization in Discrete Neural Systems. Science 1982; 215: 309-12.
42. DRATMAN MB, CRUTCHFIELD FL, AXELROD J, COLBURN RW, THOA N. Localization of Triiodothyronine in Nerve Ending Fractions of Rat Brain. Proc Natl Acad Sci USA 1976; 73: 941-4.
43. DRATMAN MB, CRUTCHFIELD FL. Synaptosomal [125i] Triiodothyronine after Intravenous [125i] Thyroxine. Am J Physiol 1978; 235: E638-647.
44. JOFFE RT, SOKOLOV ST, SINGER W. Thyroid Hormone Treatment of Depression. Thyroid 1995; 5: 235-9.
45. SCHILDKRAUT JJ. The Catecholamine Hypothesis of Affective Disorders: A Review of Supporting Evidence. Am J Psychiatry 1965; 122: 509-22.
46. ATTERWILL CK, BUNN SJ, ATKINSON DJ, SMITH SL, HEAL DJ. Effects of Thyroid Status on Presynaptic Alpha 2-Adrenoceptor Function and Beta-Adrenoceptor Binding in the Rat Brain. J Neural Transm 1984; 59: 43-55.
47. WHYBROW PC, PRANGE AJ JR. A Hypothesis of Thyroid-Catecholamine-Receptor Interaction. Its Relevance to Affective Illness. Arch Gen Psychiatry 1981; 38: 106-13.
48. BILEZIKIAN JP, LOEB JN. The Influence of Hyperthyroidism and Hypothyroidism on Alpha- and Beta-Adrenergic Receptor Systems and Adrenergic Responsiveness. Endocr Rev 1983; 4: 378-88.
49. KIRKEGAARD C, FABER J. The Role of Thyroid Hormones in Depression. Eur J Endocrinol 1998; 138: 1-9.
50. SAVARD P, MERAND Y, DI PAOLO T, DUPONT A. Effects of Thyroid State on Serotonin, 5-Hydroxyindoleacetic Acid and Substance P Contents in Discrete Brain Nuclei of Adult Rats. Neuroscience 1983; 10: 1399-404.
51. SANDRINI M, VITALE G, VERGONI AV, OTTANI A, BERTOLINI A. Effect of Acute and Chronic Treatment with Triiodothyronine on Serotonin Levels and Serotonergic Receptor Subtypes in the Rat Brain. Life Sci 1996; 58: 1551-9.
52. BAUER M, HEINZ A, WHYBROW PC. Thyroid Hormones, Serotonin and Mood: Of Synergy and Significance in the Adult Brain. Mol Psychiatry 2002; 7: 140-56.
53. UPADHYAYA I, AGRAWAL JK, DUBEY GP, UDUPA KN. Biogenic Amines and Thyrotoxicosis. Acta Endocrinol (Copenh) 1992; 126: 315-8.
54. CLEARE AJ, MCGREGOR A, O'KEANE V. Neuroendocrine Evidence for an Association between Hypothyroidism, Reduced Central 5-Ht Activity and Depression. Clin Endocrinol (Oxf) 1995; 43: 713-9.
55. SINGHAL RL, RASTOGI RB, HRDINA PD. Brain Biogenic Amines and Altered Thyroid Function. Life Sci 1975; 17: 1617-26.
56. RASTOGI RB, SINGHAL RL. Influence of Neonatal and Adult Hyperthyroidism on Behavior and Biosynthetic Capacity for Norepinephrine, Dopamine and 5-Hydroxytryptamine in Rat Brain. J Pharmacol Exp Ther 1976; 198: 609-18.
57. ATTERWILL CK. Effect of Acute and Chronic Tri-Iodothyronine (T3) Administration to Rats on Central 5-Ht and Dopamine-Mediated Behavioural Responses and Related Brain Biochemistry. Neuropharmacology 1981; 20: 131-44.
58. PINNA G, BROEDEL O, ERAVCI M, STOLTENBURG-DIDINGER G, PLUECKHAN H, FUXIUS S ET AL. Thyroid Hormones in the Rat Amygdala as Common Targets for Antidepressant Drugs, Mood Stabilizers, and Sleep Deprivation. Biological Psychiatry 2003; 54: 1049-59.
59. BSCHOR T, BAETHGE C, ADLI M, LEWITZKA U, EICHMANN U, BAUER M. Hypothalamic-Pituitary-Thyroid System Activity During Lithium Augmentation Therapy in Patients with Unipolar Major Depression. J Psychiatry Neurosci 2003; 28: 210-16.
60. HAGGERTY JJ JR, SILVA SG, MARQUARDT M, MASON GA, CHANG HY, EVANS DL ET AL. Prevalence of Antithyroid Antibodies in Mood Disorders. Depress Anxiety 1997; 5: 91-6.
61. RAPAPORT MH, SCHMIDT ME, RISINGER R, MANJI H. The Effects of Prolonged Lithium Exposure on the Immune System of Normal Control Subjects: Serial Serum Soluble Interleukin-2 Receptor and Antithyroid Antibody Measurements. Biol Psychiatry 1994; 35: 761-6.
62. BOCCHETTA A, BERNARDI F, PEDDITZI M, LOVISELLI A, VELLUZZI F, MARTINO E ET AL. Thyroid Abnormalities During Lithium Treatment. Acta Psychiatr Scand 1991; 83: 193-8.
63. BOCCHETTA A, BERNARDI F, BURRAI C, PEDDITZI M, LOVISELLI A, VELLUZZI F ET AL. The Course of Thyroid Abnormalities During Lithium Treatment: A Two-Year Follow-up Study. Acta Psychiatr Scand 1992; 86: 38-41.
64. HAGGERTY JJ JR, EVANS DL, GOLDEN RN, PEDERSEN CA, SIMON JS, NEMEROFF CB. The Presence of Antithyroid Antibodies in Patients with Affective and Nonaffective Psychiatric Disorders. Biol Psychiatry 1990; 27: 51-60.
65. MYERS DH, CARTER RA, BURNS BH, ARMOND A, HUSSAIN SB, CHENGAPA VK. A Prospective Study of the Effects of Lithium on Thyroid Function and on the Prevalence of Antithyroid Antibodies. Psychol Med 1985; 15: 55-61.
66. DENIKER P, EYQUEM A, BERNHEIM R, LOO H, DELARUE P. Thyroid Autoantibody Levels During Lithium Therapy. Neuropsychobiology 1978; 4: 270-5.
67. BARCLAY ML, BROWNLIE BE, TURNER JG, WELLS JE. Lithium Associated Thyrotoxicosis: A Report of 14 Cases, with Statistical Analysis of Incidence. Clin Endocrinol (Oxf) 1994; 40: 759-64.
68. YUKSEL A, YALCIN E, CENANI A. Influence of Long-Term Carbamazepine Treatment on Thyroid Function. Acta Paediatr Jpn 1993; 35: 229-32.
69. ISOJARVI JI, PAKARINEN AJ, MYLLYLA VV. Thyroid Function with Antiepileptic Drugs. Epilepsia 1992; 33: 142-8.
70. EIRIS-PUNAL J, DEL RÍO-GARMA M, DEL RÍO-GARMA MC, LOJO-ROCAMONDE S, NOVO-RODRÍGUEZ I, CASTRO-GAGO M. Long-Term Treatment of Children with Epilepsy with Valproate or Carbamazepine May Cause Subclinical Hypothyroidism. Epilepsia 1999; 40: 1761-6.
71. ZHU SQ, LIU XM, RUAN XZ, CAI Z. Changes of Thyroid Hormone Levels in Epileptic Patients. J Tongji Med Univ 1994; 14: 119-23.
72. ISOJARVI JIT, TURKKA J, PAKARINEN AJ, KOTILA M, RATTYA J, MYLLYLA W. Thyroid Function in Men Taking Carbamazepine, Oxcarbazepine, or Valproate for Epilepsy. Epilepsia 2001; 42: 930-4.
73. PREMACHANDRA BN, RADPARVAR A, BURMAN K, WILLIAMS IK. Apparent Increase in Type I 5′-Deiodinase Activity Induced by Antiepileptic Medication in Mentally Retarded Subjects. Horm Res 2002; 58: 273-8.
74. ERICSSON UB, BJERRE I, FORSGREN M, IVARSSON SA. Thyroglobulin and Thyroid Hormones in Patients on Long-Term Treatment with Phenytoin, Carbamazepine, and Valproic Acid. Epilepsia 1985; 26: 594-6.
75. LARKIN JG, MACPHEE GJ, BEASTALL GH, BRODIE MJ. Thyroid Hormone Concentrations in Epileptic Patients. Eur J Clin Pharmacol 1989; 36: 213-6.
76. BRADY KT, LYDIARD RB, KELLNER CH, JOFFE R, LAIRD LK, MORTON WA ET AL. A Comparison of the Effects of Imipramine and Fluvoxamine on the Thyroid Axis. Biol Psychiatry 1994; 36: 778-9.
77. BRADY KT, ANTON RF. The Thyroid Axis and Desipramine Treatment in Depression. Biol Psychiatry 1989; 25: 703-9.
78. SHELTON RC, WINN S, EKHATORE N, LOOSEN PT. The Effects of Antidepressants on the Thyroid Axis in Depression. Biol Psychiatry 1993; 33: 120-6.
79. JOFFE RT, SINGER W. Effect of Phenelzine on Thyroid Function in Depressed Patients. Biol Psychiatry 1987; 22: 1033-5.
80. FERET BM, CALEY CF. Possible Hypothyroidism Associated with Quetiapine. Ann Pharmacother 2000; 34: 483-6.
81. MCMANUS DQ, ARVANITIS LA, KOWALCYK BB. Quetiapine, a Novel Antipsychotic: Experience in Elderly Patients with Psychotic Disorders. Seroquel Trial 48 Study Group. J Clin Psychiatry 1999; 60: 292-8.
82. DUVAL F, MOKRANI MC, CROCQ MA, JAUTZ M, BAILEY P, DIEP TS ET AL. Effect of Antidepressant Medication on Morning and Evening Thyroid Function Tests During a Major Depressive Episode. Arch Gen Psychiatry 1996; 53: 833-40.
83. SOKOLOV ST, KUTCHER SP, JOFFE RT. Changes in Thyroid Hormone Levels Associated with Desipramine Response in Adolescent Depression. Prog Neuropsychopharmacol Biol Psychiatry 1996; 20: 1053-63.
84. JOFFE RT, SINGER W. Antidepressants and Thyroid Hormone Levels. Acta Med Austriaca 1992; 19 Suppl 1: 96-7.
85. KUSALIC M, ENGELSMANN F, BRADWEJN J. Thyroid Functioning During Treatment for Depression. J Psychiatry Neurosci 1993; 18: 260-3.
86. BAUMGARTNER A, CAMPOS-BARROS A, GAIO U, HESSENIUS C, FREGE I, MEINHOLD H. Effects of Lithium on Thyroid Hormone Metabolism in Rat Frontal Cortex. Biol Psychiatry 1994; 36: 771-4.
87. BAUMGARTNER A, CAMPOS-BARROS A, GAIO U, HESSENIUS C, FLECHNER A, MEINHOLD H. Carbamazepine Affects Triiodothyronine Production and Metabolization in Rat Hippocampus. Life Sci 1994; 54: PL401-407.
88. BAUMGARTNER A, DUBEYKO M, CAMPOS-BARROS A, ERAVCI M, MEINHOLD H. Subchronic Administration of Fluoxetine to Rats Affects Triiodothyronine Production and Deiodination in Regions of the Cortex and in the Limbic Forebrain. Brain Res 1994; 635: 68-74.
89. CAMPOS-BARROS A, MEINHOLD H, STULA M, MULLER F, KOHLER R, ERAVCI M ET AL. The Influence of Desipramine on Thyroid Hormone Metabolism in Rat Brain. J Pharmacol Exp Ther 1994; 268: 1143-52.
90. BARSANO CP. Other Forms of Primary Hypothyroidism. En: The Thyroid. Utigerm R, Lippincot-Raven, 1996; 771-2.
91. ROY-BYRNE PP, JOFFE RT, UHDE TW. Carbamazepine and Thyroid Function in Affective II Patient. Clinical and Theoretical Implications. Arch Gen Psychiatry 1984; 41: 1150-3.
92. WENZEL KW. Disturbances of Thyroid Function Tests by Drugs. Acta Med Austriaca 1996; 23: 57-60.
93. BAUMGARTNER A, GRAF KJ, KURTEN I, MEINHOLD H. The Hypothalamic-Pituitary- Thyroid Axis in Psychiatric Patients and Healthy Subjects: Parts 1-4. Psychiatry Res 1988; 24: 271-332.
94. KIRKEGAARD C, FABER J. Free Thyroxine and 3,3′, 5′-Triiodothyronine Levels in Cerebrospinal Fluid in Patients with Endogenous Depression. Acta Endocrinol (Copenh) 1991; 124: 166-72.
95. KIRKEGAARD C, FABER J. Influence of Free Thyroid Hormone Levels on the TSH Response to TRH in Endogenous Depression. Psychoneuroendocrinology 1986; 11: 491-7.
96. REFETOFF S. Resistance to Thyroid Hormone. Curr Ther Endocrinol Metab 1997; 6: 132-4.
97. WEISS RE, REFETOFF S. Resistance to Thyroid Hormone. Rev Endocr Metab Disord 2000; 1: 97-108.